INNOVATION1 BIOTECH INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/253af8f9-8cab-4972-98f9-6770343770e0/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-1.4M | 2022-09-01 – 2023-08-31 | evidence 0001477932-24-000223 |
| FY 2022 | $-5.2M | 2021-09-01 – 2022-08-31 | evidence 0001477932-24-000223 |
| FY 2021 | $-258.4k | 2020-09-01 – 2021-08-31 | evidence 0001477932-22-009309 |
| FY 2020 | $-216.9k | 2019-09-01 – 2020-08-31 | evidence 0001477932-21-009127 |
| FY 2019 | $-626.7k | 2018-09-01 – 2019-08-31 | evidence 0001477932-20-007273 |
| FY 2018 | $-436.1k | 2017-09-01 – 2018-08-31 | evidence 0001477932-18-005998 |
| FY 2015 | $31.1k | 2014-08-01 – 2016-02-29 | evidence 0001477932-16-012665 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).